EFMC-YMCS 2016
Conferences > Archives > EFMC-YMCS 2016
Thursday September 1, 2016
14:15Registration
15:00Welcome and opening
15:00Session Chair
Prof. Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium)
15:05Case Histories of Fragment-Based Drug Discovery.
Dr David REES
(ASTEX PHARMACEUTICALS, Cambridge, United Kingdom)
15:35Heterocycles and Medicinal Chemistry: the Importance of Innovative Synthesis
Dr Anthony WOOD
(PFIZER, Waltham, United States)
YMCS Competition Presentation Session I
16:05New Avenues in Protein Labeling - Exploiting Dna for Directing Chemical Reactions
Winner of the young medicinal chemist meeting in Denmark (CP01)
Dr Anne Louise Bank KODAL
(NOVO NORDISK, BagsvŠrd, Denmark)
16:25Drug Design, Synthesis and Biological Evaluation of Antiretroviral and Anticancer Agents
Winner of the young medicinal chemist meeting in Italy (CP02)
Dr Valeria FAMILGLINI
(UNIVERSITY OF ROME, Rome, Italy)
16:45Development of Potent, Cell-Active Inhibitors of the Mycobacterium Tuberculosis Cholesterol Oxidase Cyp125 (OC01)
Ms Madeline KAVANAGH
(UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)
17:05Flash Poster Presentations
FP01- Toward Libraries of Artificial Macrocycles
Mrs Eman ABD ELRAHEEM
(GRONINGEN UNIVERSITY, Groningen, The Netherlands)
FP02 - Discovery, Structural Exploration and Biological Profiling of a Novel Class of Antimycobacterial Dpre1 Inhibitors
Ms Olga BALABON
(UNIVERSITY OF ANTWERP, Wilrijk, Belgium)
FP03 - Orally Bioavailable Antimalarial 4(1h)-Quinolone Prodrugs with Single-Dose Cures
Dr Fabian BROCKMEYER
(NORTHEASTERN UNIVERSITY, Germany)
FP04 - Developement of Synthesis Methodology for Dna-Encoded Small Molecule Screening Libraries
Mrs Mateja KLIKA SKOPIC
(TECHNISCHE UNIVERSIT─T DORTMUND, Dortmund, Germany)
FP05 - Fishing for an Off-Target": Deconvoluting the Molecular Mechanism of Gpcr-Induced Macrophage Chemotaxis"
Dr Maria CHATZOPOULOU
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
FP06 - Design, Synthesis and Pharmacological Evaluation of Fluorescent Tools for Studying Cannabinoid Type 2 Receptor
Ms Anna COOPER
(UNIVERSITY OF OTAGO, Dunedin, New Zealand)
FP07 - Development of Novel, Selective and Irreversible Pi3kδ Inhibitors
Mr Sam DALTON
(UNIVERSITY OF STRATHCLYDE, Glasgow, United Kingdom)
FP08 - Identification of Novel Non-Natural Supramolecular Ligands as Stabilizers of 14-3-3? Protein-Protein Interactions
Dr Alba GIGANTE
(DUISBURG ESSEN UNIVERSITY, Tres Cantos-Madrid, Spain)
FP09 - Targets in Orphan Diseases and Their Repurposing Candidates - Analysis with a Knime Workflow Using Open Phacts
Ms Jana GURINOVA
(UNIVERSITY OF VIENNA, Vienna, Austria)
FP10 - Selectivity Profiling of the Human Monoamine Transporters: A Case Study on Cathinone Analogs
Ms Eva HELLSBERG
(UNIVERSITY OF VIENNA, Vienna, Austria)
FP11 - Photoswitchable 4-(Piperidin-4-Yl)-1-Hydroxypyrazole Analogues for the Gaba Type A Receptors
Ms Henriette KIHL
(UNIVERSITY OF COPENHAGEN, Copenhagen, Denmark)
FP12 - Extending Sar of Bile Acids as Fxr/Tgr5 Modulators: Synthesis and Biological Activity of Ring C Modified Cdca Derivatives
Ms Serena MOSTARDA
(UNIVERSIT└ DEGLI STUDI DI PERUGIA, Perugia, Italy)
FP13 - Lead Optimisation of a Novel Class of Trypanosomacidal Agents
Ms Harriet NEWSON
(UNIVERSITY OF WESTERN AUSTRALIA, Australia)
FP14 - Synthesis and Biological Evaluation of Diaromatic Guanidinium-Like Derivatives as Protein Kinase Inhibitors for the Treatment of Cancer
Ms Viola PREVITALI
(TRINITY COLLEGE DUBLIN, Dublin, Ireland)
FP15 - Development of Novel 1,4-Benzodiazepines as Antitrypanosomal Agents
Dr Santo PREVITI
(UNIVERSITY OF MESSINA, Messina, Italy)
FP16 - Determining the Binding Mode of 3-(1-Alkyl-1h-Imidazol-5-Yl)-1h-Indoles
Dr Adam HOGENDORF
(MAJ INSTITUTE OF PHARMACOLOGY, POLISH ACADEMY OF SCIENCES, Krakow, Poland)
FP17 - Targeting the Human Dihydroorotate Dehydrogenase (Hdhodh) by a Scaffold Hopping Bioisosteric Approach Using Hydroxylated Pentaatomic Heterocycles
Dr Stefano SAINAS
(UNIVERSITY OF TORINO, Torino, Italy)
FP18 - Towards the Elucidation of the Mechanism of Action of Small Molecule Upregulators of Utrophin Using Chemical Proteomics
Dr Aini VUORINEN
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
FP19 - Development of an Albumin-Binding Ligand for Prolonging the Plasma Half-Life of Peptide Therapeutics
Mr Alessandro ZORZI
(ECOLE POLYTECHNIQUE F╔D╔RALE DE LAUSANNE , Lausanne, Switzerland)
FP20 - Near-Infrared (Nir) Photothermal Therapy Using Biocompatible Palladium Nanoparticles
Dr Belen RUBIO RUIZ
(UNIVERSITY OF EDINBURGH, Edinburgh, United Kingdom)
17:45YMCS Poster presentation session & Networking drink
19:00End of the day
Friday September 2, 2016
YMCS Competition Presentation Session II
08:30Antimalarial Drug Discovery: Exploring the Mep Pathway
Winner of the young medicinal chemist meeting in the United Kingdom (CP03)
Ms Kathryn PRICE
(UNIVERSITY OF LIVERPOOL, Liverpool, United Kingdom)
08:50Drugging the Undrugguble: Targeting Challenging E3 Ligases
Winner of the young medicinal chemist meeting in Spain (CP04)
Dr Carles GALDEANO
(UNIVERSITAT DE BARCELONA, Barcelona, Spain)
09:10Development of Highly Selective and Reversible Diacylglycerol Lipase Inhibitors
Winner of the young medicinal chemist meeting in The Netherlands (CP05)
Dr Freek JANSSEN
(LEIDEN UNIVERSITY, Nijmegen, The Netherlands)
09:30Functional Lipidomics-Based Lead Discovery Reveals Novel Role of Phospholipids in Vitamin A Signaling
Winner of the young medicinal chemist meeting in Germany (CP06)
Dr Andreas KOEBERLE
(UNIVERSITY OF JENA, Jena, Germany)
09:50Design, Synthesis and Biological Evaluation of Selective CDK Inhibitors based on Flavopiridol Structure
Winner of the young medicinal chemist meeting in Greece (CP07)
Dr Nikitia MEXIA
(UNIVERSITY OF ATHENS, Leeds, United Kingdom)
10:10Coffee break
YMCS Competition Presentation Session III
10:35Design and Synthesis of 2,2'-Diindolylmethanes to Selectively Target Certain G-Quadruplex Dna Structures
Winner of the young medicinal chemist meeting in Sweden (CP08)
Dr Madeleine LIVENDAHL
(UMEA UNIVERSITY, Umeň, Sweden)
10:55Stable, Effective, and Selective Anticancer Phenolato Titanium(Iv) Complexes
Winner of the young medicinal chemist meeting in Israel (CP09)
Mrs Sigalit MEKER
(THE HEBREW UNIVERSITY OF JERUSALEM, Jerusalem, Israel)
11:15Glyco-Conjugated Photosensitizers: From Synthesis to Validation in Cancer Photodynamic Therapy
Winner of the young medicinal chemist meeting in Portugal (CP10)
Ms Patricia PEREIRA
(UNIVERSIDADE DE AVEIRO, Aveiro, Portugal)
11:35Discovery of Cct251921: A Potent, Selective and Orally Bioavailable Small Molecule Modulator of the Mediator Complex-Associated Kinases Cdk8 and Cdk19 (OC02)
Dr Aurelie MALLINGER
(INSTITUTE OF CANCER RESEARCH, London, United Kingdom)
11:55Lunch
YMCS Competition Presentation Session IV
13:15How to Design Cell Permeable Non-Peptidic Macrocycles (OC03)
Dr Bj÷rn OVER
(MACROCYCLE ADME, BEYOND RO5 AND NATURAL PRODUCT-FRAGMENTS, Landvetter, Sweden)
13:35New 3d-Scaffolds for Fragment-Based Lead Discovery (Fbld): Exploration of Chemical Space Using Functionalized Spirohydantoins
Winner of the young medicinal chemist meeting in France (CP11)
Mr Hugues PREVET
(LABORATORY U1177 - UNIVERSITY OF LILLE, Lille, France)
13:55Discovery Of Novel Atpase Inhibitors Of Dna Gyrase And Topoisomerase Iv Starting From Marine Sponge Alkaloid Oroidin
Winner of the young medicinal chemist meeting in Slovenia (CP12)
Dr Tihomir TOMASIC
(UNIVERSITY OF LJUBLJANA, Ljubljana, Slovenia)
14:15Purine Mimicking 3'-Ethynylribofuranose Nucleosides: New Opportunities for an Old Sugar Modification
Winner of the young medicinal chemist meeting in Belgium (KVCV) (CP13)
Mr Fabian HULPIA
(UGENT, Ghent, Belgium)
14:35Experimental Platform for Characterization and High-Throughput Screening of Acetylcholinesterase Inhibitors
Winner of the young medicinal chemist meeting in Poland (CP14)
Dr Piotr DRACZKOWSKI
(UNIVERSITY OF LUBLIN, Lublin, Poland)
14:55Novel Derivatives of the Tspo Ligand Dpa-714 For in Vivo Pet Imaging of Neuroinflammation (OC04)
Mrs Fanny CACHEUX
(CEA, Orsay, France)
15:15Voting Break
15:30Closing and award ceremony

Copyright 2019 LD Organisation sprl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys